Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.065 USD | -2.48% | -6.05% | +1.51% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 923M |
---|---|---|---|---|---|
Net income 2024 * | -182M | Net income 2025 * | -206M | EV / Sales 2024 * | - |
Net cash position 2024 * | 207M | Net cash position 2025 * | 168M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.34
x | P/E ratio 2025 * |
-5.06
x | Employees | 76 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.4% |
Latest transcript on Centessa Pharmaceuticals plc
1 day | -0.96% | ||
1 week | -5.16% | ||
Current month | -9.72% | ||
1 month | -7.29% | ||
3 months | -27.20% | ||
6 months | +27.23% | ||
Current year | +3.89% |
Managers | Title | Age | Since |
---|---|---|---|
Saurabh Saha
CEO | Chief Executive Officer | 47 | 20-12-31 |
Director of Finance/CFO | 53 | 21-02-28 | |
Ellie Im
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 61 | 21-02-22 | |
Chairman | 54 | 20-10-31 | |
Brett Zbar
BRD | Director/Board Member | 51 | 20-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 8.08 | -2.30% | 75 683 |
24-05-24 | 8.27 | -0.96% | 108,684 |
24-05-23 | 8.35 | -4.57% | 293,347 |
24-05-22 | 8.75 | +1.74% | 212,155 |
24-05-21 | 8.6 | -1.38% | 612,133 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.89% | 923M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+42.32% | 40.47B | |
-10.02% | 27.17B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- CNTA Stock